nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—CYP1A2—urine—polycystic ovary syndrome	0.0158	0.112	CbGeAlD
Domperidone—Sertindole—ADRA1D—polycystic ovary syndrome	0.0139	0.179	CrCbGaD
Domperidone—Droperidol—ADRA1A—polycystic ovary syndrome	0.0124	0.16	CrCbGaD
Domperidone—Sertindole—ADRA1B—polycystic ovary syndrome	0.0118	0.153	CrCbGaD
Domperidone—CYP3A4—urine—polycystic ovary syndrome	0.0114	0.0811	CbGeAlD
Domperidone—CYP2D6—urine—polycystic ovary syndrome	0.0112	0.0798	CbGeAlD
Domperidone—Propericiazine—ADRA1B—polycystic ovary syndrome	0.0101	0.13	CrCbGaD
Domperidone—Sertindole—ADRA1A—polycystic ovary syndrome	0.00797	0.103	CrCbGaD
Domperidone—Nefazodone—ADRA1B—polycystic ovary syndrome	0.00718	0.0926	CrCbGaD
Domperidone—CYP3A7—endocrine gland—polycystic ovary syndrome	0.00716	0.0509	CbGeAlD
Domperidone—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.00486	0.0627	CrCbGaD
Domperidone—Nefazodone—ADRA1A—polycystic ovary syndrome	0.00483	0.0623	CrCbGaD
Domperidone—Trazodone—ADRA1A—polycystic ovary syndrome	0.00447	0.0577	CrCbGaD
Domperidone—KCNH2—endometrium—polycystic ovary syndrome	0.00435	0.031	CbGeAlD
Domperidone—KCNH2—uterus—polycystic ovary syndrome	0.00401	0.0285	CbGeAlD
Domperidone—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.004	0.0285	CbGeAlD
Domperidone—DRD2—pituitary gland—polycystic ovary syndrome	0.004	0.0284	CbGeAlD
Domperidone—CYP2C8—endometrium—polycystic ovary syndrome	0.00398	0.0283	CbGeAlD
Domperidone—KCNH2—pituitary gland—polycystic ovary syndrome	0.00394	0.028	CbGeAlD
Domperidone—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00361	0.0256	CbGeAlD
Domperidone—KCNH2—adrenal gland—polycystic ovary syndrome	0.00352	0.025	CbGeAlD
Domperidone—KCNH2—female gonad—polycystic ovary syndrome	0.00328	0.0233	CbGeAlD
Domperidone—KCNH2—vagina—polycystic ovary syndrome	0.00326	0.0232	CbGeAlD
Domperidone—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00324	0.023	CbGeAlD
Domperidone—DRD2—endocrine gland—polycystic ovary syndrome	0.0031	0.022	CbGeAlD
Domperidone—KCNH2—endocrine gland—polycystic ovary syndrome	0.00305	0.0217	CbGeAlD
Domperidone—CYP2C8—vagina—polycystic ovary syndrome	0.00298	0.0212	CbGeAlD
Domperidone—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00289	0.0205	CbGeAlD
Domperidone—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00279	0.0199	CbGeAlD
Domperidone—CYP3A5—female gonad—polycystic ovary syndrome	0.00271	0.0193	CbGeAlD
Domperidone—CYP3A5—vagina—polycystic ovary syndrome	0.00269	0.0192	CbGeAlD
Domperidone—CYP2B6—vagina—polycystic ovary syndrome	0.00268	0.019	CbGeAlD
Domperidone—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00261	0.0186	CbGeAlD
Domperidone—ABCB1—embryo—polycystic ovary syndrome	0.00261	0.0186	CbGeAlD
Domperidone—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00252	0.0179	CbGeAlD
Domperidone—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00251	0.0178	CbGeAlD
Domperidone—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00214	0.0152	CbGeAlD
Domperidone—CYP2D6—female gonad—polycystic ovary syndrome	0.002	0.0142	CbGeAlD
Domperidone—ABCB1—endometrium—polycystic ovary syndrome	0.00191	0.0136	CbGeAlD
Domperidone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00189	0.0134	CbGeAlD
Domperidone—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00186	0.0132	CbGeAlD
Domperidone—ABCB1—uterus—polycystic ovary syndrome	0.00176	0.0125	CbGeAlD
Domperidone—ABCB1—pituitary gland—polycystic ovary syndrome	0.00173	0.0123	CbGeAlD
Domperidone—ABCB1—adipose tissue—polycystic ovary syndrome	0.00172	0.0122	CbGeAlD
Domperidone—ABCB1—adrenal gland—polycystic ovary syndrome	0.00154	0.011	CbGeAlD
Domperidone—ABCB1—female gonad—polycystic ovary syndrome	0.00144	0.0102	CbGeAlD
Domperidone—ABCB1—vagina—polycystic ovary syndrome	0.00143	0.0102	CbGeAlD
Domperidone—ABCB1—endocrine gland—polycystic ovary syndrome	0.00134	0.00952	CbGeAlD
Domperidone—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	0.000194	0.000248	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000193	0.000247	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000193	0.000247	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000193	0.000247	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000193	0.000247	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000193	0.000246	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000192	0.000245	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000191	0.000245	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000191	0.000244	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00019	0.000243	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	0.00019	0.000243	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000189	0.000241	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000188	0.000241	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000188	0.000241	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000187	0.00024	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000187	0.000239	CbGpPWpGaD
Domperidone—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000185	0.000237	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000185	0.000237	CbGpPWpGaD
Domperidone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000184	0.000236	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000182	0.000233	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000181	0.000232	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000178	0.000228	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000177	0.000227	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000177	0.000226	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000177	0.000226	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000175	0.000224	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000175	0.000224	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000174	0.000222	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000173	0.000221	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000173	0.000221	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	0.000172	0.000221	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	0.000172	0.00022	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	0.000172	0.000219	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000171	0.000218	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—TH—polycystic ovary syndrome	0.000171	0.000218	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000168	0.000215	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	0.000168	0.000215	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	0.000168	0.000215	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000167	0.000213	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000166	0.000212	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	0.000165	0.000212	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000165	0.000211	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000164	0.00021	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	0.000163	0.000208	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000163	0.000208	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000163	0.000208	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000162	0.000208	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000162	0.000208	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000162	0.000207	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000162	0.000207	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	0.000162	0.000207	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	0.000159	0.000203	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000157	0.000201	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000157	0.000201	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000157	0.000201	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000156	0.0002	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000155	0.000199	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	0.000155	0.000199	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000155	0.000198	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000154	0.000198	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000154	0.000197	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000153	0.000196	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000153	0.000196	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000153	0.000195	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000153	0.000195	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—LHB—polycystic ovary syndrome	0.00015	0.000192	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	0.00015	0.000192	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000148	0.00019	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000148	0.000189	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000147	0.000188	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000147	0.000188	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000146	0.000187	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000145	0.000186	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	0.000145	0.000186	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000145	0.000185	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000145	0.000185	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000144	0.000184	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000143	0.000182	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000142	0.000182	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000141	0.000181	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	0.00014	0.000179	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	0.000139	0.000178	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000138	0.000177	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000138	0.000176	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	0.000135	0.000172	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000134	0.000172	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000134	0.000171	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000134	0.000171	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000134	0.000171	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000134	0.000171	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	0.000133	0.00017	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	0.000133	0.00017	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000132	0.000169	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000132	0.000169	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000131	0.000168	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000131	0.000167	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00013	0.000166	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000129	0.000165	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000128	0.000163	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000128	0.000163	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	0.000127	0.000162	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—TH—polycystic ovary syndrome	0.000126	0.000161	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	0.000126	0.000161	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	0.000125	0.00016	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000125	0.00016	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000125	0.00016	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000124	0.000159	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000124	0.000158	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	0.000124	0.000158	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—TH—polycystic ovary syndrome	0.000123	0.000158	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000123	0.000157	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000123	0.000157	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000123	0.000157	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	0.000122	0.000156	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	0.00012	0.000154	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.00012	0.000153	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000119	0.000153	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000119	0.000152	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000118	0.000151	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	0.000117	0.00015	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	0.000117	0.00015	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000117	0.00015	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000117	0.00015	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000117	0.000149	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000116	0.000148	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000115	0.000148	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000115	0.000147	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000113	0.000145	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	0.000113	0.000144	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000112	0.000144	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000111	0.000142	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.00011	0.000141	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000109	0.00014	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000109	0.00014	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000108	0.000138	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000107	0.000137	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—TH—polycystic ovary syndrome	0.000107	0.000137	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000106	0.000136	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000105	0.000135	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000104	0.000133	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	0.000104	0.000133	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	0.000103	0.000132	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000103	0.000132	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000103	0.000131	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000101	0.00013	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000101	0.00013	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	0.000101	0.000129	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	0.000101	0.000129	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	9.82e-05	0.000126	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.78e-05	0.000125	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	9.77e-05	0.000125	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	9.74e-05	0.000125	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	9.6e-05	0.000123	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	9.6e-05	0.000123	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	9.51e-05	0.000122	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	9.38e-05	0.00012	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	9.38e-05	0.00012	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	9.36e-05	0.00012	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—INS—polycystic ovary syndrome	9.33e-05	0.000119	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—TH—polycystic ovary syndrome	9.31e-05	0.000119	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	9.31e-05	0.000119	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.3e-05	0.000119	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.24e-05	0.000118	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	9.24e-05	0.000118	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.17e-05	0.000117	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	9.1e-05	0.000116	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	9.06e-05	0.000116	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	9.03e-05	0.000116	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.03e-05	0.000116	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	8.98e-05	0.000115	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—TH—polycystic ovary syndrome	8.77e-05	0.000112	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.75e-05	0.000112	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	8.73e-05	0.000112	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	8.72e-05	0.000112	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	8.69e-05	0.000111	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	8.68e-05	0.000111	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	8.68e-05	0.000111	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	8.59e-05	0.00011	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	8.53e-05	0.000109	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	8.52e-05	0.000109	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	8.48e-05	0.000108	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	8.31e-05	0.000106	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.25e-05	0.000106	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	8.22e-05	0.000105	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.05e-05	0.000103	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	8.05e-05	0.000103	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	8.02e-05	0.000103	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	7.88e-05	0.000101	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.8e-05	9.97e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	7.6e-05	9.72e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.52e-05	9.61e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—TH—polycystic ovary syndrome	7.43e-05	9.51e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	7.35e-05	9.39e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	7.24e-05	9.26e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	7.23e-05	9.25e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.22e-05	9.24e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	7.18e-05	9.18e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	7.16e-05	9.16e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.13e-05	9.12e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	7.04e-05	9e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	6.94e-05	8.87e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	6.91e-05	8.84e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—INS—polycystic ovary syndrome	6.9e-05	8.83e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	6.88e-05	8.8e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	6.87e-05	8.79e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.86e-05	8.78e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	6.82e-05	8.73e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	6.8e-05	8.69e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	6.78e-05	8.67e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—INS—polycystic ovary syndrome	6.74e-05	8.63e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.73e-05	8.61e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.65e-05	8.51e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	6.65e-05	8.5e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.64e-05	8.5e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.63e-05	8.48e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	6.47e-05	8.27e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	6.4e-05	8.18e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.31e-05	8.08e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	6.07e-05	7.76e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.03e-05	7.71e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	5.96e-05	7.62e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	5.87e-05	7.51e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—INS—polycystic ovary syndrome	5.84e-05	7.47e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	5.78e-05	7.39e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.74e-05	7.34e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.68e-05	7.26e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.58e-05	7.14e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	5.48e-05	7.01e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.25e-05	6.71e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	5.19e-05	6.64e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—POMC—polycystic ovary syndrome	5.12e-05	6.55e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	5.11e-05	6.53e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—INS—polycystic ovary syndrome	5.09e-05	6.51e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	5.09e-05	6.5e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.89e-05	6.25e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.82e-05	6.17e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.8e-05	6.13e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.68e-05	5.99e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.46e-05	5.71e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.34e-05	5.56e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.23e-05	5.41e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	4.14e-05	5.3e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	4.09e-05	5.23e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—INS—polycystic ovary syndrome	4.06e-05	5.2e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.94e-05	5.04e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	3.93e-05	5.02e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.2e-05	4.09e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.15e-05	4.03e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.14e-05	4.01e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	3e-05	3.84e-05	CbGpPWpGaD
